leadf
logo-loader
viewC4X Discovery Holdings PLC
(
AIM:C4XDFRA:C4J
)

C4X Discovery announce 'sizeable deal and one we're very proud of' with Sanofi worth up to €414mln

C4X Discovery's (LON:C4XD) Clive Dix talks Proactive London's Katie Pilbeam about their worldwide licensing deal with international drugs giant Sanofi worth up to €414mln.

The group will receive €7mln upfront, plus €11mln in pre-clinical payments.

The deal is for their oral IL-17A inhibitor programme, currently IL-17 monoclonal antibodies are administered by injection. Having an oral version represents a significant breakthrough.

Quick facts: C4X Discovery Holdings PLC

Follow
AIM:C4XD

Price: 32.5 GBX

Market Cap: £74.04 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE's glass is half empty despite prospect of pint as pub...

FTSE 100 opened lower on fretting about inflation and the US$2.8bn fine for Alibaba from China anti-monopoly regulator. The prospect of a drink outside of the house for the first time in months did little to lift the mood and London’s main index shed 11 points to 6,904. Today marks the UK’s...

on 12/4/21

2 min read